This should be interesting and could be a game changer for some cancer patients.
The CF33-hNIS virus, also called Vaxinia, was originally created by researchers at the City of Hope National Medical Center in California. It’s now being jointly developed with the company Imugene Limited.
Vaxinia is billed as an oncolytic virus, meaning it prefers to target and infect tumor cells. Scientists have been hopeful about using these kinds of viruses to directly kill off cancer cells for more than a century, but with limited success so far. In recent years, some teams have decided to explore a slightly different plan of attack. This genetically modified virus not only infects and harms cancer cells, but also forces these cells to become more recognizable to the immune system.
gizmodo.com
The CF33-hNIS virus, also called Vaxinia, was originally created by researchers at the City of Hope National Medical Center in California. It’s now being jointly developed with the company Imugene Limited.
Vaxinia is billed as an oncolytic virus, meaning it prefers to target and infect tumor cells. Scientists have been hopeful about using these kinds of viruses to directly kill off cancer cells for more than a century, but with limited success so far. In recent years, some teams have decided to explore a slightly different plan of attack. This genetically modified virus not only infects and harms cancer cells, but also forces these cells to become more recognizable to the immune system.
First Patient Dosed With Experimental Cancer-Killing Virus in New Trial
Vaxinia has been shown to shrink cancer tumors in animals, but its real test starts now.
gizmodo.com
